Close Menu

NEW YORK (GenomeWeb) – Invitae announced after the close of the market on Monday that it will offer $125 million worth of its common stock in a public offering.

The San Francisco-based genetic testing firm hasn't finalized the number of shares it will offer of the expected offering price. Its shares were trading down around 5 percent at $19.35 on the New York Stock Exchange on Tuesday morning.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.